review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Ralph Steinman | Q105494 |
P2093 | author name string | G Schuler | |
P2860 | cites work | A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma | Q24319940 |
Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope | Q24652858 | ||
Phenotypic analysis of antigen-specific T lymphocytes | Q28290058 | ||
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor | Q29619247 | ||
Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth | Q73585686 | ||
Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells | Q34229490 | ||
Identification of proliferating dendritic cell precursors in mouse blood | Q36231236 | ||
Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity | Q36366130 | ||
A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis | Q36366458 | ||
CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha | Q36367113 | ||
Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo | Q36367135 | ||
In vivo detection of dendritic cell antigen presentation to CD4(+) T cells. | Q36377341 | ||
Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy | Q36380365 | ||
Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR-P1) and have cytotoxic activity to select targets via a Ca2+-dependent mechanism | Q36380421 | ||
Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases | Q36380718 | ||
Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity | Q36380749 | ||
Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma | Q36763316 | ||
Tumor antigens recognized by T lymphocytes | Q40661131 | ||
Dendritic cells: from ignored cells to major players in T-cell-mediated immunity | Q40899962 | ||
Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
Developmental regulation of MHC class II transport in mouse dendritic cells. | Q41093187 | ||
The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens | Q41115110 | ||
Identification of the genes encoding cancer antigens: implications for cancer immunotherapy. | Q41196605 | ||
Fibroblasts as efficient antigen-presenting cells in lymphoid organs | Q41336467 | ||
Capture and processing of exogenous antigens for presentation on MHC molecules. | Q41464375 | ||
Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back | Q41465258 | ||
TAP off--tumors on. | Q41504939 | ||
Functions of CD40 on B cells, dendritic cells and other cells | Q41514641 | ||
New insights into the mobilization and phagocytic activity of dendritic cells | Q42142211 | ||
A novel migration pathway for rat dendritic cells from the blood: hepatic sinusoids-lymph translocation | Q43136015 | ||
Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells | Q46578425 | ||
Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. | Q52827100 | ||
Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. | Q54451826 | ||
CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis | Q57275941 | ||
Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells | Q57275942 | ||
GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells | Q59067424 | ||
Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor | Q60043767 | ||
Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy | Q70840996 | ||
Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells | Q71017514 | ||
TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors | Q71403490 | ||
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells | Q71607047 | ||
In vitro differentiation of CD34+ hematopoietic progenitor cells toward distinct dendritic cell subsets of the birbeck granule and MIIC-positive Langerhans cell and the interdigitating dendritic cell type | Q71611744 | ||
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability | Q71615065 | ||
Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha | Q71693365 | ||
Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma | Q72203307 | ||
Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma | Q73316641 | ||
Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells | Q73321311 | ||
Flt3 ligand induces tumor regression and antitumor immune responses in vivo | Q73400017 | ||
Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody | Q73479961 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell | Q7868 |
cancer | Q12078 | ||
dendritic cell | Q506253 | ||
neoplasm | Q1216998 | ||
biomedical investigative technique | Q66648976 | ||
hemic and immune systems | Q70202933 | ||
adoptive immunotherapy | Q72138716 | ||
P304 | page(s) | 1183-1187 | |
P577 | publication date | 1997-10-01 | |
1997-10-20 | |||
P1433 | published in | Journal of Experimental Medicine | Q3186912 |
P1476 | title | Dendritic cells as adjuvants for immune-mediated resistance to tumors | |
P478 | volume | 186 |